Lawmakers urge tighter controls on hydrocodone

By Megan R. Wilson A bipartisan duo from the House is pressuring federal regulators to crack down on prescriptions for the painkiller hydrocodone. Reps. Vern Buchanan (R-Fla.) and Edward ...

Boehringer Lung Drug Wins U.S. FDA Advisory Panel Backing

By Anna Edney Boehringer Ingelheim GmbH, the world’s biggest family-owned drugmaker, won the backing of U.S. regulatory advisers for a drug to treat a lung disease that is the nation’s ...

FDA gives new drug application approval to Isis

CARLSBAD, Calif. (AP) — Drug developer Isis Pharmaceuticals Inc. and partner Genzyme announced Tuesday that the U.S. Food and Drug Administration has approved their new drug application ...

And Now, For Some More Pharma Layoffs…

By Ed Silverman The rash of job cuts continues among drugmakers and biotechs as they struggle to develop new medications and grapple with assorted setbacks in the laboratory and elsewhere. ...

Conflicts Policies And Antidepressant Prescribing

By Ed Silverman Do conflict of interest policies adopted by residency programs actually work? To test this notion, a group of researchers examined prescribing data for several widely ...

UK Pharma & Docs Inch Toward Payment Disclosure

BThe push for greater transparency about financial ties between the pharmaceutical industry and physicians has prompted a collection of 20 medical and industry trade organizations to ...

Samsung snatches up CT scanner maker NeuroLogica

By Mark Hollmer Samsung is diving deeper into the medical imaging business. The South Korean consumer electronics giant snatched up NeuroLogica, a Massachusetts maker of portable ...

Illumina soars on deCode sale, revenue jump

By Damian Garde Illumina ($ILMN) rode a spike in sales and a lump cashout from its stake in deCode Genetics to a record fourth quarter, bringing in $72 million in net income on $309 ...

Report: Bausch eyeing IPO amid sale talk

By Damian Garde Warburg Pincus, which owns eye care giant Bausch + Lomb, has apparently struggled to find a buyer willing to pony up the reported $10 billion asking price, and now The ...

Witness: J&J lowered own standards to deem metal hips ‘safe’

By Damian Garde When Johnson & Johnson’s ($JNJ) metal-on-metal hip implants failed an internal safety test, the company opted against fixing the issue and instead just ...

UPDATED: Boston Scientific targets another 1,000 jobs in expanded restructuring

Meanwhile, the company’s 2012 Q4 earnings show signs of stabilization By Mark Hollmer Boston Scientific ($BSX) anticipates slashing between 900 and 1,000 additional jobs beyond ...

GSK in Joint Venture for Pediatric Vaccine

By Stephanie Sutton GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination   paediatric vaccine to help ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS